APA (7th ed.) Citation

KT, D. V., D, K., MJ, K., JR, R., C, S., JK, H., . . . HM, D. (2025). The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions. Transplantation direct, 11(3), e1757. https://doi.org/10.1097/TXD.0000000000001757

Chicago Style (17th ed.) Citation

KT, Del Valle, et al. "The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions." Transplantation Direct 11, no. 3 (2025): e1757. https://doi.org/10.1097/TXD.0000000000001757.

MLA (9th ed.) Citation

KT, Del Valle, et al. "The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions." Transplantation Direct, vol. 11, no. 3, 2025, p. e1757, https://doi.org/10.1097/TXD.0000000000001757.